ESourcing Capability Model

Clinical ink Expands Patient Engagement Solutions with Behavioral Diagnostic Tool SPUR™

Retrieved on: 
Monday, November 13, 2023
Motivation, Behavior, ESourcing Capability Model, Clinical trial, Data, Obesity, Digital, Cognition, MD, American Opportunity Tax Credit, Biomarker, Diabetes, Clinical, SPUR, Medical imaging

Winston Salem, NC, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Clinical ink , a global life science technology company, is expanding its patient engagement suite with the inclusion of the SPUR behavioral diagnostic tool created by Observia .

Key Points: 
  • Winston Salem, NC, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Clinical ink , a global life science technology company, is expanding its patient engagement suite with the inclusion of the SPUR behavioral diagnostic tool created by Observia .
  • SPUR TM is a behavioral diagnostic tool that is used to determine adherence to protocol and drugs, standardize lifestyle, and modify behavior by personalized intervention.
  • The collaboration with Observia allows Clinical ink to capture a holistic view of patient behavior together with clinical outcomes and digital biomarkers.
  • We strongly share Clinical ink’s vision that improving patient experience equals improving clinical trial performance,” says Kevin Dolgin , Head of R&D at Observia.

SDC Announces Partnership with CRIO on eSource Initiative

Retrieved on: 
Tuesday, November 14, 2023
Data Management, Health, Technology, Health Technology, Software, Clinical Trials, ECG, SDC, Clinical trial, Data management, CRIO, Patient, Multimedia, ESourcing Capability Model, Fujitsu Technology Solutions, EDC, Calendar, CFR

Continuing the momentum of technology solution innovations after its recent release of SDC InsightsTM, SDC is proud to partner with CRIO to bring eSource functionality in-house to better serve clients and their clinical needs.

Key Points: 
  • Continuing the momentum of technology solution innovations after its recent release of SDC InsightsTM, SDC is proud to partner with CRIO to bring eSource functionality in-house to better serve clients and their clinical needs.
  • View the full release here: https://www.businesswire.com/news/home/20231114143441/en/
    “With SDC’s in-house developers, we can efficiently meet the individual needs of each protocol with CRIO eSource, a compliant solution that harnesses real-time data to streamline clinical compliance and reduce transcription errors” says Quan Doan, Vice President, Technology Solutions.
  • SDC’s eSource solution, powered by CRIO, is a comprehensive, 21 CFR Part 11 compliant system that enables staff to capture data in real-time.
  • SDC also just launched SDC Capture™ -- ePRO technology to ensure an optimized user experience for clients and sites with superior data reliability and robust data security.

Auguste Escoffier Global Solutions Expands Culinary and Hospitality Workforce Development Platform

Retrieved on: 
Monday, November 20, 2023
Acquisition, Workforce, Gallup, Econnect, Multimedia, ESourcing Capability Model, Triumph, National Restaurant Association, Aramark, Improper integral, Landry's, Palisade, Face, Management, Nursing, Sodexo

SCHAUMBURG, Ill., Nov. 20, 2023 /PRNewswire/ -- Auguste Escoffier Global Solutions, (Escoffier Global) a Triumph Higher Education Group LLC company, announces the expansion of its workforce development solutions to address culinary and hospitality industry gaps with innovative, customizable tools and strategies for hiring, training and retaining professional staff.

Key Points: 
  • Escoffier Global pools resources and expertise from sister organization, Auguste Escoffier School of Culinary Arts, the largest culinary school brand in the U.S. (based on comparable student population data currently reported in IPEDS) .
  • "The hiring struggle is real for the hard-hit culinary and hospitality industries looking to connect skilled talent with unfilled positions," said Denise Sullivan, vice president of Enterprise Solutions for Auguste Escoffier Global Solutions.
  • Auguste Escoffier Global Solutions (Escoffier Global) is an Auguste Escoffier School of Culinary Arts sister company and part of the Triumph Higher Education Group LLC.
  • Escoffier Global is a leading provider of hiring and training solutions for the culinary and hospitality industry.

Vial Announces Collaborative Alliance with Mason

Retrieved on: 
Wednesday, November 15, 2023
SAN, ESourcing Capability Model, Entrepreneurship, Clinical trial, Tablet, Patient, Clinical data management, Data collection, EDC, Digital technology, Partnership, Mason, Pharmaceutical industry, Vaccine, Vial

As part of the collaboration, Mason will provide Vial with hardware as a service for clinical sites, enabling remote management of devices for eSource at a global scale.

Key Points: 
  • As part of the collaboration, Mason will provide Vial with hardware as a service for clinical sites, enabling remote management of devices for eSource at a global scale.
  • This partnership empowers Vial to focus on accelerating the development of new therapies and devices for its sponsors and patients.
  • Mason, founded by President Jim Xiao, is enthusiastic about joining forces with Vial in this venture.
  • The collaboration between Vial and Mason has already yielded significant results, with Mason's tablets successfully deployed to clinical trial sites across the United States.

A Step-by-Step Approach to EHR eSource in Clinical Trials, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Wednesday, October 11, 2023
EDC, EHR, ESourcing Capability Model, Risk, ROI, Roger Hawkins (drummer), Acquisition, Openclinica, Clinical trial, Cal Collins, Map, Management, Pharmaceutical industry, Cryptocurrency

TORONTO, Oct. 11, 2023 /PRNewswire-PRWeb/ -- The shift from manual data entry of medical records to the automatic acquisition of data from multiple real-world sources is no longer a 'nice to have' in clinical trials. In our post-pandemic landscape, sponsors embracing EHR eSource realize key competitive advantages:

Key Points: 
  • In this free webinar, learn how to adopt an incremental approach to eSource (EHR to EDC integration) across multiple trial scenarios to overcome real and perceived challenges.
  • Attendees will learn how a strategic approach to EHR eSource today builds a strong competitive advantage.
  • In our post-pandemic landscape, sponsors embracing EHR eSource realize key competitive advantages:
    "EHR eSource represents a revolutionary advancement for clinical trial stakeholders," said Cal Collins, OpenClinica CEO.
  • "EHR eSource represents a revolutionary advancement for clinical trial stakeholders," said Cal Collins, OpenClinica CEO.

OpenClinica Strengthens Commitment to eSource and SMART on FHIR

Retrieved on: 
Wednesday, September 20, 2023
Openclinica, Society, Health Level Seven International, Consortium, Interview, AUC, Clinical trial, FHIR, RWD, CDMS, EHR, Patient safety, Fast Healthcare Interoperability Resources, ESourcing Capability Model, Managing editor, Festival, HL7, Conference, DIA, SMART, Cal Collins, Pharmaceutical industry

NEEDHAM, Mass., Sept. 20, 2023 /PRNewswire-PRWeb/ -- OpenClinica announced today the company joined the Society for Clinical Data Management (SCDM) eSource Implementation Consortium Taskforce. Additionally, CEO Cal Collins will lead an educational session at the SCDM Annual Conference, October 8-11, 2023, in San Diego. Collins, a steering committee member of Vulcan, one of Health Level Seven's (HL7) eight Fast Healthcare Interoperability (FHIR) Accelerators, is chairing the SCDM 2023 session, Are you ready for EHR eSource? Lessons from the field, October 11, 9:00-10:00 am Pacific. In the October 11 session, Collins and panelists will discuss experiences, strategies, and proven tactics around the successful adoption and scaling of eSource integration at clinical trial sites from multiple perspectives, with a focus on EHR-to-EDC.

Key Points: 
  • Collins, a steering committee member of Vulcan , one of Health Level Seven's (HL7) eight Fast Healthcare Interoperability (FHIR) Accelerators , is chairing the SCDM 2023 session, Are you ready for EHR eSource?
  • OpenClinica's commitment to eSource and SMART on FHIR is second to none," emphasized Cal Collins.
  • "OpenClinica's commitment to eSource and SMART on FHIR is second to none," emphasized Cal Collins, OpenClinica CEO.
  • OpenClinica and Collins have created eSource and SMART on FHIR educational resources, including:
    An interview with Applied Clinical Trials, which can be viewed at: https://www.appliedclinicaltrialsonline.com/view/cal-collins-discusses-t... .

Leading Clinical Informatics Experts at EDETEK and Pfizer Partner at DPHARM Conference

Retrieved on: 
Monday, September 18, 2023
Data management, Associate Director of National Intelligence and Chief Information Officer, Aggregation, Vehicle tracking system, American Opportunity Tax Credit, Conformity, Clinical trial, Innovation, Electronic health record, Doctor of Philosophy, Movement, MS, Disruptive innovation, Patient, ESourcing Capability Model, Access, Acquisition, Title 21 CFR Part 11, Data acquisition, GDPR, Satellite navigation device, Pharmaceutical industry, Pfizer

PRINCETON, N.J., Sept. 18, 2023 /PRNewswire/ -- EDETEK Inc., a leading global provider of specialized software and services for the biopharma, devices and diagnostics industries, announced today that it will participate in a prestigious plenary roundtable session of the 2023 DPHARM (Disruptive Innovations to Modernize Clinical Research) conference. This session takes place during DPHARM Track A, on Tuesday, September 20, 2023 at 2:50pm ET.

Key Points: 
  • "Central to our relationship with Pfizer is our implementation of EDETEK's CONFORM™ informatics platform," said Mr. Baara.
  • The EDETEK CONFORM™ platform has emerged as a transformative business and technical solution for increasingly complex clinical trials.
  • Pfizer and EDETEK are collaborating to speed access to clinical data, promote interoperability and enable data visualizations and analytics to drive faster decision-making capabilities in clinical operations.
  • "We have participated in every DPHARM conference since 2017 and are once again very excited to participate in the 2023 conference," said Jian Chen, President, EDETEK.

Vial Announces Collaborative Alliance with MLM Medical Labs

Retrieved on: 
Friday, September 15, 2023
Partnership, Cras, Clinical data management, Information technology, MLM, Digital technology, ESourcing Capability Model, Collection, Patient, SAN, Entrepreneurship, ChromeOS, EDC, Fine chemical, Vaccine, Vial

SAN FRANCISCO, Sept. 14, 2023 /PRNewswire/ -- Vial , a global tech-driven CRO providing next-generation clinical trial management services, has partnered with MLM Medical Labs ("MLM"), an international central and specialty laboratory with locations in Europe and North America.

Key Points: 
  • SAN FRANCISCO, Sept. 14, 2023 /PRNewswire/ -- Vial , a global tech-driven CRO providing next-generation clinical trial management services, has partnered with MLM Medical Labs ("MLM"), an international central and specialty laboratory with locations in Europe and North America.
  • MLM will provide Vial with central laboratory solutions, including study setup management, sample analysis, proprietary MLM Kit Building® - which includes customized, all-in-one sample collections kits, tracking bar-codes, and color-coded labeling solutions - and more.
  • MLM also provides a complete sample management solution and a real-time, secured clinical data portal through its proprietary MLM Sample Storage System® and MLM-Online®.
  • Vial EDC is a modern, intuitive, and hyper-responsive EDC platform delivering a consumer-grade experience and next-generation performance to eClinical software.

EmVenio Research Partners with RealTime Software Solutions for Advanced Mobile-Optimized Technology Solutions

Retrieved on: 
Thursday, September 14, 2023
ESourcing Capability Model, ChromeOS, Partnership, Wi-Fi, Clinical trial, Research, CTMS, Comprehension, RealTime, Online shopping

DURHAM, N.C., Sept. 14, 2023 /PRNewswire/ -- EmVenio Research , a global network of mobile research sites providing localized trial access to diverse and underserved communities, today announced a strategic partnership with RealTime Software Solutions, LLC , a renowned provider of cutting-edge, digitally-optimized technologies designed for clinical research sites, CROs (clinical research organizations) and sponsors.

Key Points: 
  • DURHAM, N.C., Sept. 14, 2023 /PRNewswire/ -- EmVenio Research , a global network of mobile research sites providing localized trial access to diverse and underserved communities, today announced a strategic partnership with RealTime Software Solutions, LLC , a renowned provider of cutting-edge, digitally-optimized technologies designed for clinical research sites, CROs (clinical research organizations) and sponsors.
  • "RealTime Software Solutions offers a comprehensive tool that will enable the EmVenio team to standardize and optimize research processes to ultimately deliver high-quality data to our sponsors and CROs," said Mark Campbell, EmVenio's chief operating officer.
  • RealTime Software Solutions provides a robust full-stack Site Operations Management System (SOMS) for clinical research, empowering EmVenio to streamline research processes, enhance efficiency and foster innovation.
  • This partnership will allow EmVenio to remain focused on its core mission of delivering localized trial access while harnessing RealTime Software Solutions' technology to efficiently manage research operations.

Rockset Raises $44 Million in Funding to Power Search, Analytics, and AI Applications

Retrieved on: 
Tuesday, August 29, 2023
Database, Metadata, SQL, Sequoia, RocksDB, Synthetic media, River, OpenSearch, Intelligence, General partnership, Blog, Index, Amazon DynamoDB, ESourcing Capability Model, Machine learning, SAN, Generative, Growth, Icon Ventures, Rest, What-not, Clinical, Data science, Cryptocurrency, Information technology, Online shopping, AI, Elasticsearch

For two years in a row, Rockset has tripled its revenue and doubled its customer base as real-time AI adoption grows at a breakneck pace.

Key Points: 
  • For two years in a row, Rockset has tripled its revenue and doubled its customer base as real-time AI adoption grows at a breakneck pace.
  • “Enterprises are doubling down on their initiatives to bring new AI applications to production.
  • We have been blown away by the speed of Rockset and its ability to support complex filters, joins, and aggregations.
  • “All told, when including its reduced management burden, Rockset is 3x more cost-effective for us than Elasticsearch .”
    Learn more about the funding round and the future of real-time search, analytics and AI: https://rockset.com/blog/rockset-raises-44m-AI-search-analytics